| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5882789 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 24 Pages |
Abstract
Allotransplant benefited younger patients and those in CR at the time of transplant. The adverse effect of high-risk cytogenetics may be overcome by the allo-HCT.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Binod Dhakal, Anita D'Souza, Michael Martens, Jonathan Kapke, Alexandra M. Harrington, Marcelo Pasquini, Wael Saber, William R. Drobyski, Mei Jie Zhang, Mehdi Hamadani, Parameswaran N. Hari,